Effect of atorvastatin on plasma fibrinogen [4]

Lancet

Volumn 351, Issue 9102, 1998, Pages 569-570

  Wierzbicki, Anthony S ^a   Lumb, Peter J ^b   Semra, Yemane K ^b   Crook, Martin A ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CHOLESTEROL; CREATINE KINASE; FIBRINOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIVER ENZYME; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; CARDIOVASCULAR RISK; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILIAL HYPERLIPEMIA; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; LETTER; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; TIME;

EID: 0032554333     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)78556-1     Document Type: Article

References (5)

1. 1 Black DM. Atorvastatin: a step ahead for HMG-CoA reductase inhibitors. Atherosclerosis X 1995: 307-10.
2. 2 Marais AD, Firth JC, Bateman ME, Byrnes P, Martens C, Mountney J. Atorvastatin: an effective agent in familial hypercholesterolaemia. Arterioscler Thromb Vasc Biol 1997; 17: 1527-32.
3. 3 Davidson MH, McKenney J, Stein E, et al. Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolaemia. Am J Cardiol 1997; 79: 1475-81.
4. 4 Tsuda Y, Satoh K, Kitadai M, Takahashi T, Izumi Y, Hosomi N. Effects of pravastatin sodium and simvastatin on plasma fibrinogen and blood rheology in type II hypercholesterolaemia. Atherosclerosis 1996; 122: 225-33.
5. 5 Branchi A, Rovellini A, Sommariva D, Gugliandolo AG, Fasoli A. Effect of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen in patients with primary hypercholesterolaemia. Thromb Haemostasis 1993; 70: 241-43.